my email to Nader after the CC
"Overall I think the call
my email to Nader after the CC
"Overall I think the call went well minus the ridiculous Q&A session. Maybe when topline results are reported we can get pre-screened questions that are insightful and add color to the call.
Keep up the good work. Can't wait to have Leronlimab in my arsenal when I treat patients.
***What has not been asked or emphasized is the mechanism of action (MOA) that set Leronlimab apart from the other 2000 candidates. THIS IS IMPORTANT. I believe as a physician scientist that the MOA is incredibly UNIVERSAL and can be implicated in ALL respiratory viral illnesses. Just imagine that instead of the standard Azithromycin/Prednisone script given to COPD exacerbations, a leronlimab shot would be the new standard of care (SOC).
I totally understand that we need to get a victory and approval before all the other implications of this drug but I hope we "don't miss seeing the forest for the trees." Basically to reiterate, our drug is not unique to COVID-19 it is the MOA, that is unique to the drug and gives us victory! THE MOA IS UNIVERSAL TO INFLAMMATORY conditions (NASH, MS, spondyloarthropathies etc...). Coronavirus is a zoonotic virus that causes the common cold (2nd most common) but this drug could be used in basically ANY AND ALL VIRAL DISEASES, BECAUSE WE REPROGRAM THE IMMUNE SYSTEM IN OUR FAVOR. This is why our drug is worth 1000x any specific MAB to COVID (ie REGN) or antiviral (GILD).
PLEASE help the general investor and medical community realize what we have and our potential. It's mind blowing to put it lightly."
11
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...
Continue Reading
Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...
Continue Reading
Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...
Continue Reading
Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...
Continue Reading
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...
Continue Reading
Top 5 Most Recently Viewed Articles
Celebrating the 2025 Diamond Supplier Award Winners Today, International Motors, LLC is excited to unveil the recipients of the prestigious 2025 Diamond Supplier Award. This annual recognition highlights suppliers who consistently show exceptional commitment to excellence, collaboration, and innovation across several crucial areas including technology, quality, delivery,...
Continue Reading
HCI Group Inc's Short Interest Overview In recent trading sessions, the short interest for HCI Group Inc (NYSE:HCI) has witnessed a considerable increase. Specifically, it has surged by 33.65% since the previous report. Presently, there are approximately 670 thousand shares that have been sold short. This figure represents around 6.99% of the total regular shares...
Continue Reading
Announcing a Special Concert Featuring Elizabeth Hainen The USA International Harp Competition Spring Concert is set to dazzle audiences with an extraordinary performance by Elizabeth Hainen, the Principal Harpist at the Philadelphia Orchestra, and the newly appointed Artistic Director of the competition. This rare opportunity will also feature talented special guests...
Continue Reading
Solid Q3 Performance by Novartis In a significant announcement, Novartis reported an impressive growth in net sales and core operating income for the third quarter. During this period, the company's net sales reached USD 13.9 billion, reflecting a growth of 7% on a constant currency basis and an 8% increase in USD terms. Core operating income showed a similar trajectory,...
Continue Reading
Celebrating Community Impact Through Wahl's Benevolent Beard Contest In a heartwarming initiative, Wahl®, the revered men's grooming leader, is once again recognizing individuals who blend their passion for grooming with a purpose. This year, Kevin Simmons, a pediatric speech pathologist, emerges as one of five finalists in the esteemed Wahl® Benevolent Beards Contest....
Continue Reading